These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10424430)

  • 1. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty.
    George J; Harats D; Bakshi E; Adler Y; Levy Y; Gilburd B; Shoenfeld Y
    Immunol Lett; 1999 Jun; 68(2-3):263-6. PubMed ID: 10424430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies.
    Sherer Y; Tenenbaum A; Praprotnik S; Shemesh J; Blank M; Fisman EZ; Harats D; George J; Levy Y; Peter JB; Motro M; Shoenfeld Y
    Cardiology; 2001; 95(1):20-4. PubMed ID: 11385187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty.
    Eber B; Schumacher M; Tatzber F; Kaufmann P; Luha O; Esterbauer H; Klein W
    Cardiology; 1994; 84(4-5):310-5. PubMed ID: 8187118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty.
    Eber B; Schumacher M; Auer-Grumbach P; Toplak H; Klein W
    Am J Cardiol; 1992 May; 69(16):1255-8. PubMed ID: 1585855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using oxidized low-density lipoprotein autoantibodies to predict restenosis after balloon angioplasty in patients with acute myocardial infarction.
    Huang CH; Chang CC; Huang CS; Kuo CL; Chen CP; Hsia CH; Chang YM; Chen HT; Feng CC; Lin LS; Yang PT; Tsai CD; Lin CS; Liu CS
    PLoS One; 2013; 8(10):e74726. PubMed ID: 24098346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis.
    Mukherjee M; De Benedictis C; Jewitt D; Kakkar VV
    Thromb Haemost; 1996 Feb; 75(2):258-60. PubMed ID: 8815572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty.
    Boullier A; Walters-Laporte E; Hamon M; Tailleux A; Amant C; Amouyel P; Fruchart J; Bertrand M; Duriez P
    Clin Chim Acta; 2000 Sep; 299(1-2):129-40. PubMed ID: 10900299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty.
    Chiarugi L; Prisco D; Antonucci E; Capanni M; Fedi S; Liotta AA; Margheri M; Simonetti I; Gensini GF; Abbate R
    Atherosclerosis; 2001 Jan; 154(1):129-35. PubMed ID: 11137091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.
    Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):204-9. PubMed ID: 10634819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of predictive factors associated with recurrent restenosis after second percutaneous transluminal coronary angioplasty].
    Kishi K; Hiasa Y; Tanaka H; Kinoshita M; Tanimoto M; Wada T; Aihara T
    J Cardiol; 1997 Jan; 29(1):7-12. PubMed ID: 9023674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
    Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
    Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
    Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
    Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
    Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing.
    Bresee SJ; Jacobs AK; Garber GR; Ruocco NA; Mills RM; Bergelson BA; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Nov; 68(11):1158-62. PubMed ID: 1951074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
    Yamashita K; Tasaki H; Tsuda Y; Himeno E; Nakashima Y
    Ther Apher; 1998 Aug; 2(3):210-7. PubMed ID: 10227772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Hearn JA; Donohue BC; Ba'albaki H; Douglas JS; King SB; Lembo NJ; Roubin GS; Sgoutas DS
    Am J Cardiol; 1992 Mar; 69(8):736-9. PubMed ID: 1532112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.